Invitae is a biotechnology company specializing in genetic testing, providing medical-grade genetic testing and counseling services to empower individuals to make informed decisions about their health. The company also focuses on sustainability and environmental and social governance (ESG) as part of its mission.

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

COM:INVITAE

Invitae Corp.

Last Close

0.03

14/02 20:59

Market Cap

5.44M

Beta: -

Volume Today

22.46M

Avg: -

market

industry

website

crunchbase

ipo date

peer of

competitor of

Metrics